$4.90
-0.300 (-5.77%)
At Close: Aug 07, 2026
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
08:04am, Friday, 07'th Aug 2026
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical Q2 Earnings Call Highlights
02:05am, Friday, 07'th Aug 2026
Outset Medical NASDAQ: OM reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
06:40pm, Thursday, 06'th Aug 2026
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to a loss of $0.84 per share a year ago.
Outset Medical Reports Second Quarter 2026 Results
04:01pm, Thursday, 06'th Aug 2026
SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis w
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
12:00pm, Wednesday, 29'th Jul 2026
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 29, 20
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
11:19am, Wednesday, 29'th Jul 2026
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby y
Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
09:00am, Thursday, 23'rd Jul 2026
SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and comp
SAN FRANCISCO, July 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Outset Medical, Inc. (NASDAQ: OM) investors that the firm is investigating potential legal claims arising from alleg
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 02'nd Jul 2026
SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis w
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
05:25am, Friday, 19'th Jun 2026
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
GENEVA--(BUSINESS WIRE)--OM Pharma Unveils the Largest Multi-Country Real-World Evidence Study on Broncho Vaxom® (OM 85) for RTI Prevention at EAACI 2026.
Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé
06:00am, Tuesday, 09'th Jun 2026
MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") ( TSX: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce initial results from the 2
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
02:56pm, Friday, 05'th Jun 2026
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby y
Osisko Metals Files NI 43-101 Technical Report for the Gaspé Copper Project
07:19am, Friday, 29'th May 2026
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce the filing on SEDAR+ of a techni
Osisko Metals Announces Results of Voting at 2026 Annual Meeting of Shareholders and Welcomes Keith McKay to the Board
05:00pm, Thursday, 28'th May 2026
TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (TSX:OM "Osisko" or the "Corporation") announces the results of its annual meeting of shareholders (the "Meeting") held earlier tod
Sign In
Buy OM